Synthetic Thioesters of Thiamine: Promising Tools for Slowing Progression of Neurodegenerative Diseases
International Journal of Molecular Sciences · 10.07.2023 · 24 (14) · 11296
DOI: 10.3390/ijms241411296 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.07.2023. Verfasst von Lucien Bettendorff. Beteiligte Einrichtung: Laboratory of Neurophysiology, GIGA Neurosciences, University of Liège, 4000 Liège, Belgium. Hauptthemen laut MEDLINE: Neurodegenerative Diseases. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 119 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fonds de la Recherche Scientifique—FNRS.
Abstract (Originalsprache)
Thiamine (vitamin B1) is essential for the brain. This is attributed to the coenzyme role of thiamine diphosphate (ThDP) in glucose and energy metabolism. The synthetic thiamine prodrug, the thioester benfotiamine (BFT), has been extensively studied and has beneficial effects both in rodent models of neurodegeneration and in human clinical studies. BFT has no known adverse effects and improves cognitive outcomes in patients with mild Alzheimer’s disease. In cell culture and animal models, BFT has antioxidant and anti-inflammatory properties that seem to be mediated by a mechanism independent of the coenzyme function of ThDP. Recent in vitro studies show that another thiamine thioester, O,S-dibenzoylthiamine (DBT), is even more efficient than BFT, especially with respect to its anti-inflammatory potency, and is effective at lower concentrations. Thiamine thioesters have pleiotropic properties linked to an increase in circulating thiamine concentrations and possibly in hitherto unidentified open thiazole ring derivatives. The identification of the active neuroprotective metabolites and the clarification of their mechanism of action open extremely promising perspectives in the field of neurodegenerative, neurodevelopmental, and psychiatric conditions. The present review aims to summarize existing data on the neuroprotective effects of thiamine thioesters and give a comprehensive account.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Neurophysiology, GIGA Neurosciences, University of Liège, 4000 Liège, Belgium.
ORCID-Profile: Lucien Bettendorff
Förderung
- Fonds de la Recherche Scientifique—FNRS
Zitieren
APA
Bettendorff, L. (2023). Synthetic Thioesters of Thiamine: Promising Tools for Slowing Progression of Neurodegenerative Diseases. International Journal of Molecular Sciences, 24(14), 11296. https://doi.org/10.3390/ijms241411296
Vancouver
Bettendorff L. Synthetic Thioesters of Thiamine: Promising Tools for Slowing Progression of Neurodegenerative Diseases. International Journal of Molecular Sciences. 2023;24(14):11296. doi:10.3390/ijms241411296
BibTeX
@article{Bettendorff2023,
author = {Bettendorff, Lucien},
title = {Synthetic Thioesters of Thiamine: Promising Tools for Slowing Progression of Neurodegenerative Diseases},
journal = {International Journal of Molecular Sciences},
year = {2023},
volume = {24},
number = {14},
pages = {11296},
doi = {10.3390/ijms241411296}
}
EUVIMED